Table 1.
Primers and Taqman assays used
| Genotyping primers | |
| B5-Fwd | 5′-ACGCGTCGACCTTGTGTTAGTAATTCAGCC-3′ |
| mT4-Rev | 5′-CAGAGTATGTAAGTCCAGCAGC-3′ |
| LacZ-Rev | 5′-GGGACGACGACAGTATCGGCCT-3′ |
| RT-PCR primers | |
| BGAL-FwdNew | 5′-GCACGGTTACGATGCGCCCA-3′ |
| BGAL-RevnNew | 5′-GCGCTGGAGTGACGGCAGTT -3′ |
| mT1-For | 5′-TATTTCCTTCGCCAGTCCCTG-3′ |
| mT4R-Rev | 5′-CAGAGTATGTAAGTCCAGCAGC-3′ |
| mHPRT1-For | 5′-GCTTGCTGGTGAAAAGGACCTCTCGAAG-3′ |
| mHPRT1-Rev | 5′-CCCTGAAGTACTCATTATAGTCAAGGGCAT-3′ |
| TaqMan gene | Assay ID |
| HO-1 | Mm00516005_m1 |
| BNP | Mm01255770_g1 |
| p53 | Mm00519571_m1 |
| Rn18s | Mm03928990_g1 |
The genotyping primers were used to verify the presence of FtMt gene or of LacZ gene in the FtMt locus. RT-PCR primers were used for identification of the transcripts of FtMt, β-Gal, and HPRT1 in the testis of the mice. The TaqMan gene expression assays were used to quantify HO-1, BNP, p53, and Rn18s transcripts in the heart of the treated mice